Abstract
Magnetic resonance-diffusion tensor imaging (MR-DTI) has been used in the microvascular decompression and gamma knife radiosurgery in trigeminal neuralgia (TN) patients; however, use of percutaneous stereotactic radiofrequency rhizotomy (PSR) to target an abnormal trigeminal ganglion (ab-TG) is unreported. Fractional anisotropy (FA), mean and radial diffusivity (MD and RD, respectively), and axial diffusivity (AD) of the trigeminal nerve (CNV) were measured in 20 TN patients and 40 healthy control participants immediately post PSR, at 6-months, and at 1 year. Longitudinal alteration of the diffusivity metrics and any correlation with treatment effects, or prognoses, were analyzed. In the TN group, either low FA (value < 0.30) or a decreased range compared to the adjacent FA (dFA) > 17% defined an ab-TG. Two-to-three days post PSR, all 15 patients reported decreased pain scores with increased FA at the ab-TG (P < 0.001), but decreased MD and RD (P < 0.01 each). Treatment remained effective in 10 of 14 patients (71.4%) and 8 of 12 patients (66.7%) at the 6-month and 1-year follow-ups, respectively. In patients with ab-TGs, there was a significant difference in treatment outcomes between patients with low FA values (9 of 10; 90%) and patients with dFA (2 of 5; 40%) (P < 0.05). MR-DTI with diffusivity metrics correlated microstructural CNV abnormalities with PSR outcomes. Of all the diffusivity metrics, FA could be considered a novel objective quantitative indicator of treatment effects and a potential indicator of PSR effectiveness in TN patients.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Introduction
Trigeminal neuralgia (TN), a severe neuropathic pain disorder, affects one or more branches of the trigeminal nerve (CNV, cranial nerve five) and occurs in 4–5 new patients per 100,000 annually1,2. Percutaneous stereotactic radiofrequency rhizotomy (PSR) is a minimally invasive therapy for TN, particularly when no neurovascular contact is observed on imaging3,4, and is often the primary treatment option for patients who are older, weaker, have had recurrence after failed microvascular decompression (MVD), or who are reluctant to undergo MVD5,6. A more quantitative neuroimaging technique, magnetic resonance-diffusion tensor imaging (MR-DTI), has been widely used in the study of TN6,7,8,9,10,11.
MR-DTI is based on the principle of the motion of water molecules in neural tissue. DTI has recently become widely used for the non-invasive delineation of nerve fiber tracts via tractography12,13 which can accurately delineate the visual 3D anatomical structures of nerve tracts and their branches, otherwise not observed on traditional morphological MRI14,15. A tract-specific DTI protocol indirectly assesses the microstructures of the nerve fiber, axon, and myelin2,16, thus providing a clearer visualization and estimation of the changes in the neural tract at the microscopic level, which is crucial in understanding the pathogenesis and treatment of TN11,13,16,17.
Recently, the DTI studies9,18,19,20 in patients with TN has focused on the root entry zone (REZ) of the CNV; however, no studies on abnormal trigeminal ganglion (ab-TG) have been reported. The aim of this was to investigate whether changes in diffusivity metrics during radiofrequency treatment in TN patients with ab-TG of TN could be correlated with outcomes.
Materials and methods
Study design and participants
This observational study involved 20 TN patients (TN group) and 40 healthy control participants. The TN group was further divided into an operative subgroup and a nonoperative subgroup. All patients underwent MR-DTI. The inclusion criteria for the TN group were as follows: (1) TN diagnosis according to the International Classification of Headache Disorders (3rd edition)21; (2) treatment between March 2021 and June 2022 in the Department of Neurosurgery at China-Japan Union Hospital of Jilin University (Changchun, Jilin, China). The inclusion criteria for the healthy control participants were as follows: (1) no prior medical record of neurological, psychiatric illnesses; (2) no experience of trigeminal nerve-related pain in the previous 6 months.
All study procedures were approved by the Institutional Review Board of China-Japan Union Hospital of Jilin University. All participants provided written informed consent. All methods were performed in accordance with the relevant guidelines and regulations.
MR-DTI data acquisition, postprocessing, and analysis
Magnetic resonance-DTI images, including high-resolution T1-weighted 3D-sagittal anatomical images and DTI images, were acquired from a 3.0 Tesla Siemens MR scanner18,22. Anatomical images: in-plane voxel size = 0.9 × 0.9 mm2, slice thickness = 0.9 mm, 192 slices, matrix = 256 × 256, field of view = 24 × 24 cm2, echo time (TE) = 2.3 ms, repetition time (TR) = 2300 ms, and inversion time = 900 ms. DTI protocol: spin-echo EPI sequence, b value = 0 and 1000 s/mm2, 12 b0 Averages, 3 b1000 Averages, 72-direction, in-plane voxel size = 2 × 2 mm2, slice thickness of 2 mm with no gap, 30 continuous slices, matrix size = 256 × 256, field of view = 25 × 25 cm2, flip angle = 90°, TE = 95 ms, TR = 4100 ms. The integral parallel acquisition technique was used, and the acceleration factor was 2, which can decrease image distortion from susceptibility artifacts. A b value of 1000 s/mm2 was used with 3× image averaging and a b value of 0 s/mm2 was used with 12× image averaging. Diffusion tensor images were motion and eddy current corrected before image processing, with appropriate correction applied to the b-matrix.
Image postprocessing was performed in a 3D Slicer V4.11 software package utilities (http://www.slicer.org/). The process generated scalar maps of fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD), and axial diffusivity (AD). A tractography was generated from the DTI data, which entails postprocessing Digital Imaging and Communications in Medicine (DICOM) files. For each participant, fiber tracts of the CNV were generated from tractography of the region of interest seeds on both sides of the CNV in axial view FA maps7,15. Image reconstruction was used to characterize the major diffusion direction of the fiber and fiber tracking from the pons to a ganglion within Meckel's cave.
The CNV tract was manually divided into eight segments (as Segs. 1–8) from the REZ in the pons to the TG in Meckel’s cavity according to the coronal DTI image (Fig. 1). Since the TG is crescent-shaped, the width of the TG ranged from 3.58 to 8.19 mm23,24. Thus, we selected four slices to extract diffusivity metrics of the TG (ie, Segs. 4–7. Seg. 1 was in the pons, Segs. 2–3 were in the REZ, and Seg. 8 was beyond the TG. To obtain diffusivity metrics (FA, MD, AD, and RD) of the CNV (Fig. 2), the centroid was placed in each tract segment on the successive coronal slices of scalar maps, then the position of the centroid was validated on the 3D planes and the CNV tracts15,18. In total, 1 to 3 DTI scans (preoperative, postoperative, and follow-up) were performed on patients in the TN group and one scan performed on participants in the control group.
Detected abnormal segments of TGs in the analysis of diffusivity metrics of CNV
The trendline of diffusivity metrics was drawn according to the corresponding values of the eight CNV segments. The diffusivity metrics in DTI, such as FA and MD, were used to detect the abnormalities in the TG of TN patients. By analyzing diffusivity metrics in the TG segments in healthy control participants, the means ± standard deviations (SD) of the FA and a decreased range of FA (dFA) compared with the adjacent segment in controls were calculated and considered the reference for the abnormal FA threshold. The low limit of the FA on TG segments was 0.30 and the upper limit of the 95% confidence interval of the decreased range for TG segments was 16.39%. Therefore, the FA of an ab-TG was either < 0.30 or dFA > 17%. The means ± SDs of the MD, RD, and AD in the TG segments were also calculated. Abnormal TG segment characteristics such as position and size were measured in the diffusion-tensor images (Fig. 3).
Classification
Trigeminal neuralgia can be categorized as classical TN (CTN), idiopathic TN (ITN), or secondary TN. Classical TN is the most common and is thought to be caused by neurovascular compression (NVC). The intensity of NVC can be divided into grade I (simple contact), grade II (a displacement or distortion), or grade III (a thinning nerve)25,26,27. According to the property of pain, TN is divided into Type I (paroxysmal pain) and Type II (continuous pain)21.
Treatment
TN patients in the operative subgroup underwent PSR treatment. PSRs were performed using a stereotactic bidirectional approach-guiding technique5,28,29. The PSR was performed using Komai’s CT-Stereotactic Frame (Mizuho Medical Innovation https://www.mizuho.co.jp/en/neurosurgery/). 150 mm-long radiofrequency probe (diameter, 0.9 mm with 5-mm exposed tip) was used during PSR. During PSR operations, after fixing the stereotactic frame according to the 3D data of foramen ovale target (FOT) and the data of facial entry point, adjust the arc angle and the arm angle of stereotactic frame according to the characteristic of TGT.
Meanwhile, TN patients in the nonoperative subgroup received medical treatment (carbamazepine or oxcarbazepine).
Treatment evaluation and follow-up
Treatment effects were evaluated postoperatively (2–3 days) and at follow-up (3–6 months and at 1 year postoperative) using visual analogue scale (VAS) scores and diffusivity metrics (FA, MD, RD, and AD). A 75% reduction of pain scores was used to distinguish effective from ineffective treatments20,30.
Statistical Analysis
Summary statistics were computed for all DTI metric values. Differences between the control group and the TN group were determined using the t-test. Differences in the treatment effects and diffusivity metrics on TG were analyzed using the chi-square test. The DTI metrics were compared pre-and postoperatively in the TN group using the one-way repeated measures analysis of variance (ANOVA). If the assumption of “sphericity” is not satisfied, the F values can be corrected by the Greenhouse–Geisser method. All statistical analyses were performed using SPSS v26.0 (IBM, USA). In all statistical tests, P < 0.05 was considered statistically significant.
Ethics approval and consent to participate
The study was approved by the Ethics Committee of the China-Japan Union Hospital of Jilin University. Written informed consent was obtained from the patient for the publication of this record and accompanying images.
Results
Patient characteristics
In the control group, ages ranged from 24 to 67 years and included 12 males and 28 females. In the TN group, the baseline characteristics of the 20 TN patients are summarized in Table 1. There were no significant differences in sexes or ages between the two groups. Fifteen patients in the TN operative subgroup had ab-TGs (Nos. 1–15). Five patients in the TN nonoperative subgroup selected medical treatment (Nos. 16–20).
CNV diffusivity metrics in healthy control participants
Fractional anisotropy values gradually decreased from the pons to the TG; MD, AD, and RD values gradually increased from the pons to the TG. There were no major fluctuations along the CNV segments (Fig. 4). FA mean ± SD values in the TG segments were calculated (Table 2) and a lower limit of the normal range in the TG established at 0.30. The decreased ranges of FA values compared to adjacent TG segments were 10.66%, 1.44%, 1.18%, and 3.70% for Segs. 4, 5, 6, and 7, respectively. A 95% confidence interval of the decreased range for each segment as a reference for abnormal FA and the upper limit of dFA was established at 16.39%. Hence, either FA < 0.30 or dFA > 17% defined an ab-TG.
The means ± SD of MD, RD, and AD on TG segments 4 through 7 were calculated (Table 2). Abnormal diffusivity metrics were determined as MD > 0.0022, RD > 0.0017, or AD > 0.0034.
CNV diffusivity metrics in TN patients
In the TN group, 18 patients with VAS of 10 had ab-TGs. Two patients with VAS of 3 or 4 did not have ab-TGs. The rate of detecting ab-TGs was 90% (18/20) in TN patients, and the rate was 100% in patients with VAS of 10.
In the 18 patients with ab-TGs, a total of 30 affected branches and 32 abnormal segments were identified (Fig. 5). In the operative TN subgroup, ab-TGs were confirmed by low FA (< 0.30) in 10 patients (10/15, 66.7%) and by dFA > 17% (non-low FA) in another five patients (5/15, 33.3%). The distribution of the abnormal branches and abnormal FA segments in the TGs are shown in Fig. 5).
The distribution of segments with the lowest FA in the ab-TG was as follows (Fig. 6): the abnormal TG segment in V1-affected patients was in Seg. 7 (80.0%, 4/5); in V2-affected patients was in Segs. 6 or Seg. 7 (75.0%, 6/8); and in V3-affected patients was in Seg. 6 (100.0%, 2/2).
The trendline of FA on the unaffected side of the CNV in four patients was accordant with the smooth trendline of FA in controls while 11 patients did not follow this pattern (Fig. 7, Table 3).
In the REZ of the affected CNV side, a sharp decrease in FA was noted 8 patients and no decrease in FA was noted in 7 patients (Table 3).
PSR treatment
The success rate of single-puncture access was 93.3% (14/15) in TN patients who underwent PSR. During the procedure, the electrophysiology sensory test voltage ranged from 0.15 to 0.30 V.
Operation efficacy and complications
The immediate effects of PSR were evaluated 2–3 days postoperatively. VAS decreased postoperatively to 1–3 in 13 patients (one patient with VAS of 3 and 12 patients with VAS of 1) and to 4 in 2 patients. The postoperative VAS decrease ranged from 60 to 90% in all patients. Postoperative DTI scans were performed on 14 patients (one patient had no postoperative DTI scan). After radiofrequency treatment of the TG, the postoperative FA of the abnormal TG segment had increased by 14.1% in 1 patient (No. 8), 33.8–81.8% in 9 patients, and 124.2–274.9% in 4 patients. There were significant differences between the preoperative and postoperative FA (P < 0.001), MD (P < 0.01), and RD (P < 0.01) values in the abnormal TG segments, but not in AD values (P > 0.05) (Fig. 8). On the unaffected CNV side, diffusivity metrics between preoperative and postoperative illustrated no significant differences (Table 4) suggesting that preoperative FA, MD, and RD values changed significantly after PSR in patients with ab-TGs.
By analyzing diffusivity metrics and VAS preoperatively and postoperatively, FA and MD values were synchronously changed in detecting the abnormal CNV segment and the diffusivity metrics (FA, MD) and the VAS changed simultaneously. The changes in direction of the FA and MD values were inverted in DTI. After treatment, the changes in FA in all patients (100%, 14/14) and MD in 78.6% of patients (11/14) were consistent with changes in VAS.
Fifteen patients who underwent PSR had follow-up evaluations at the 3- to 6-month postoperative time period; 14 of these patients were evaluated at the 6-month mark. Five patients underwent DTI at the 3- to 6-month follow-up. VAS was 0–2 in 10 patients and 3–4 in 4 patients (No. 8, 10, 11 and 12). Treatment was effective in 11 patients (11/15, 73.3%) (Fig. 9) and ineffective in 4 patients (Fig. 10). Of the 11 patients with effective treatments, 9 patients (81.8%) had low FA values (i.e., < 0.30) and 2 patients (18.2%) had FA values ≥ 0.30 in the TG. Of the 4 patients classified as having ineffective treatment, small focal areas of recurrent pain were noted including 3 patients (Nos. 8, 10 and 12) with FA values ≥ 0.30 and 1 patient (No. 11) with an FA value < 0.30 in the TG. No patient experienced recurrence of the whole affected area.
In 5 patients who underwent DTI at the 3- to 6-month follow-up period, 4 patients with effective treatment had further FA increases on TG segments that ranged from 24.7 to 103.8% when compared to their preoperative values. One patient with ineffective treatment experienced a decrease in their FA value on TG segments by 26.6% when compared to their 3-day postoperative FA value.
Treatment outcomes could be correlated with the TG segments in patients with the lowest FA values (Fig. 11). Of the patients with low FA in the affected side of the TG, nine patients experienced effective treatments (9/10, 90%) and treatment was ineffective in one patient (No. 11) (Table 3, Fig. 11). Of the patients with FA ≥ 0.30 in the affected side of the TG, 2 patients experienced effective treatments (2/5, 40%) and treatment was ineffective in 3 patients (3/5, 60%; No. 8, 10, 12). The chi-square test was used for comparing the differences between the lowest FA values and the treatment outcomes (chi-square value: 4.261, P < 0.05).
The FA manifestations of the affected REZ were normal in 7 patients and abnormal in 8 patients at the preoperative evaluation (Table 3). Of the 7 patients with normal FA manifestations, treatment was effective in 6 patients (6/7, 86%) and ineffective in one patient. Of the 8 patients with abnormal FA manifestations, treatment was effective in 5 patients (5/8, 62.5%) and ineffective in 3 patients (3/8, 37.5%).
The FA manifestations of the unaffected CNV were normal in 4 patients and abnormal in 11 patients at the preoperative evaluation (Fig. 7, Table 3). Of the 4 patients with normal FA manifestations of the unaffected side CNV, treatment was effective in all patients (4/4, 100%). Of the 11 patients with abnormal FA manifestations of the unaffected side CNV, treatment was effective in 7 patients (7/11, 63.6%) and ineffective in 4 patients (4/11, 36.4%).
Diffusivity metrics in each of the 4 patients (Patient Nos. 8, 10, 11 and 12) with ineffective treatment noted at the 3- to 6-month postoperative period revealed the following: Patient No. 8 had low FA on the affected TG and an abnormal unaffected side of the CNV; Patient No. 10 had an FA value ≥ 0.30 on the affected TG, decreased FA on the REZ of the affected side CNV, and an abnormal unaffected side of the CNV; Patient No. 11 had an FA value ≥ 0.30 on the affected TG and an abnormal FA value of the unaffected side CNV; and Patient No. 12 had an FA value ≥ 0.30 on the affected TG and decreased FA on the REZ of the affected side CNV. Overall, 3 patients (75%, 3/4) had FA values ≥ 0.30 on the affected TG and 4 patients (100%) had decreased FA values on the REZ of the affected side CNV and/or an abnormal unaffected side of the CNV.
Twelve patients completed the 1-year follow-up. Eight patients reported effective treatments (VAS was 0–1), and the rate of effective treatment was 66.7% (8/12). In all 4 patients who had small focal areas of recurrent pain, 3 patients opted for medicinal treatment and one patient underwent MVD.
After treatment, facial numbness was noted in one patient (No. 1). None of most common complications were observed; however, Patient No. 10 experienced a rare complication of temporary apnea.
Discussion
Diffusion tensor imaging, a technique based on the principle of diffusion motion of water protons in nerve tissue, has recently received attention in TN studies. Several studies support the use of DTI in TN for its ability to expose the CNV at a microstructure level8,15,19,31,32,33,34,35,36,37. DTI has been used to evaluate the efficacy of MVD and gamma knife radiosurgery (GKRS) with the REZ for TN as the therapeutic target12,20,22. In addition, DTI is also used to detect diffusivity metrics on the CNV38 or the REZ of the CNV19 both before and after radiofrequency treatment. To date, DTI has not been used to detect the abnormal diffusion on the TG in patients with TN or to guide surgical treatment targeting. Measuring the preoperative FA of the CNV can serve as a comparator post-treatment to evaluate the efficacy of PSR.
Fractional anisotropy is the most widely used quantitative metric to comprehensively reflect the diffusion profile in the dominant diffusion direction. Because of its high sensitivity to the microstructure of myelinated axons and neural injury13,39,40, FA has been even regarded as a prognostic biomarker of MVD and GKRS outcomes9,22,41. The MD and RD change synchronously with the FA; however, abnormalities of nerves might be amplified and reflected in FA. The authors determined that an abnormal TG could be defined by both a low FA (< 0.30) or a sharp FA decrease (> 17%) and that the abnormal TG and the lowest FA segments in TN patients showed a regular distribution. David et al. reported that the TG can be divided into 3 subregions corresponding to its 3 branches42. Current study results further corroborate the CNV and TG anatomical structures suggesting the utility of diffusivity metrics as an independently reliable method of detecting the abnormal segments of the TG.
DTI was used to evaluate the efficacy9,20,22,41,43 of MVD and GKRS with the therapeutic target in REZ for TN. Diffusivity metrics, especially FA, reflect the treatment efficacy of TN patients in the nerve microstructure 19. FA is generally regarded as a quantitative, noninvasive prognostic and pathology marker of TN9,19,20,34,38,39,40,41,43. The significant change in diffusivity on TG segments induced by PSR and the change in FA in all patients (100%, 14/14) and MD in 78.6% of patients (11/14) were consistent with changes in VAS. Current study results showed that FA and MD values in TN patients with abnormal TG could be useful indicators in objectively evaluating PSR efficacy.
In the study patients who underwent PSR, all 15 observed immediate efficacies which indicated that the FA of MR-DTI plays a crucial role in guiding the TG treatment target in PSR. At the 6-month follow-up visit, 4 of 15 patients (26.7%) reported ineffective treatment including 3 of 4 patients (75%) with ab-TGs identified by FA values ≥ 0.30 and one patient with an FA value < 0.30. Recurrence shortly following radiofrequency thermocoagulation (RFT) is a known issue. Several studies report recurrence rates of approximately 20–25% 6 months following RFT 4,44,45,46. We hypothesize that the primary reason for recurrence shortly after PSR may be due to an FA value ≥ 0.30 in the TG. It seems that the degree to which the FA value in the TG is abnormal portends the effectiveness of PSR. TN patients with FA values ≥ 0.30 in the TG may be more prone to recurrence post PSR or may not be candidates for PSR at all.
It was important to try and analyze whether FA values on every segment of the CNV could portend recurrence shortly after radiofrequency treatment. TN is characterized not only by diffusion abnormalities on the CNV when compared to controls, but also by abnormalities between the affected and unaffected sides of the TG 18,31,39. By combining diffusivity metrics of the bilateral CNVs, the current study results suggest the following findings may herald effective PSR treatment: normal FA value of the unaffected side of the CNV (4/4, 100%); an FA value < 0.30 in the affected side of the TG (9/10, 90%); and a normal FA value of the affected side REZ (6/7, 86%). Patients with FA values ≥ 0.30 in the affected side of the TG (3/5, 60%), an abnormal FA value of the affected side REZ (3/8, 38%), and an abnormal FA value of the unaffected side of the CNV (4/11, 36%) typically see poorer results following PSR. Diffusivity metrics of the bilateral CNVs may be indicators to predict the effect of PSR and detecting preoperative FA values in bilateral CNVs may improve PSR efficacy rates.
The rate of effective treatment was 66.7% (8 of 12 patients) at the 1-year follow-up. Recurrences were noted in 4 four patients and were limited to small areas of focal pain. Because the recurrences occurred so shortly after PSR (i.e., within 3–5 months), the authors had the opportunity to investigate potential reasons for suboptimal efficacy.
The most common complications of radiofrequency treatment include hematoma, facial swelling, facial hypoesthesia, masticatory weakness, meningitis, and cerebrospinal fluid leakage 1,3,4,5. One of our study patients experienced facial hypoesthesia and another patient developed a rare complication of temporary apnea related to vertebrobasilar dolichoectasia6. Overall, the use of MR-DTI-guided PSR resulted in a high single-puncture success rate (93.3%, 14/15) on the TG treatment target which likely contributed to reduced potential for subsequent complications.
The study did have its limitations. A more reliable criterion for abnormal CNV needs to be established in larger studies. Expanding the sample size will help us explore whether FA can be a potential indicator for future TN molecular typing diagnoses. In addition, the applicability of abnormal TGs in patients with TN needs longer follow-up. Extending the follow-up will confirm whether adjusting the RFT dose can improve the efficacy rate in patients with dFA and may eventually expand the indications for use of RFT.
Conclusions
Microstructural abnormalities of CNV are associated with a spectrum of treatment effect in patients with TN. Utilization of MR-DTI with diffusivity metrics reveals microstructural alterations of the CNV and correlates with outcomes after PSR. Fractional anisotropy, in particular, could be considered a novel objective quantitative biomarker to assess treatment efficacy as well as a potential indicator of patient prognosis following PSR.
Data availability
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- ab-TG:
-
Abnormal trigeminal ganglion
- AD:
-
Axial diffusivity
- CNV:
-
Cranial nerve five
- CTN:
-
Classical TN
- dFA:
-
A decrease range compared with the adjacent segment of FA
- FA:
-
Fractional anisotropy
- GKRS:
-
Gamma knife radiosurgery
- ITN:
-
Idiopathic TN
- MD:
-
Mean diffusivity
- MR-DTI:
-
Magnetic resonance-diffusion tensor imaging
- MVD:
-
Microvascular decompression
- NVC:
-
Neurovascular compression
- RD:
-
Radial diffusivity
- REZ:
-
Root entry zone
- RFT:
-
Radiofrequency thermocoagulation
- PSR:
-
Percutaneous stereotactic radiofrequency rhizotomy
- SD:
-
Standard deviation
- TE:
-
Echo time
- TG:
-
Trigeminal ganglion
- TN:
-
Trigeminal neuralgia
- TR:
-
Repetition time
- VAS:
-
Visual analogue score
References
Cruccu, G., Di Stefano, G. & Truini, A. Trigeminal neuralgia. N. Engl. J. Med. 383(8), 754–762 (2020).
Li, R. et al. The integrity of the substructure of the corpus callosum in patients with right classic trigeminal neuralgia. J. Craniofac. Surg. 32(2), 632–636 (2021).
Bendtsen, L. et al. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol. 19(9), 784–796 (2020).
Wang, Z. et al. Radiofrequency thermocoagulation for the treatment of trigeminal neuralgia. Exp. Ther. Med. 23(17), 11 (2022).
Guo, Z., Wu, B., Du, C., Cheng, M. & Tian, Y. Stereotactic approach combined with 3D CT reconstruction for difficult-to-access foramen ovale on radiofrequency thermocoagulation of the Gasserian ganglion for trigeminal neuralgia. Pain Med. 17(9), 1704–1716 (2016).
Yadav, Y. R. et al. Trigeminal neuralgia. Asian J. Neurosurg. 12(4), 585–597 (2017).
Danyluk, H., Sankar, T. & Beaulieu, C. High spatial resolution nerve-specific DTI protocol outperforms whole-brain DTI protocol for imaging the trigeminal nerve in healthy individuals. NMR Biomed. 34(2), e4427 (2021).
Koh, Y. H. et al. Evaluation of trigeminal nerve tractography using two-fold-accelerated simultaneous multi-slice readout-segmented echo planar diffusion tensor imaging. Eur. Radiol. 31(2), 640–649 (2021).
Pikis, S. et al. Diffusivity metrics three months after upfront gamma knife radiosurgery for trigeminal neuralgia may be correlated with pain relief. World Neurosurg. 153, e220–e225 (2021).
Su, X. et al. Effects of the MR-DTI characteristics of the trigeminal ganglion target on radiofrequency treatment in patients with trigeminal neuralgia: A retrospective observational clinical study. Pain Res. Manage. 2023, 1–11 (2023).
Yang, S., Kwon, S. & Chang, M. C. The usefulness of diffusion tensor tractography in diagnosing neuropathic pain: A narrative review. Front. Neurosci. 15, 591018 (2021).
Basser, P. J., Mattiello, J. & LeBihan, D. MR diffusion tensor spectroscopy and imaging. Biophys. J. 66(1), 259–267 (1994).
Voss, H. U. & Schiff, N. D. MRI of neuronal network structure, function, and plasticity. Neurother. Prog. Restor. Neurosci. Neurol. 175, 483–496 (2009).
Mungoven, T. J. et al. Microstructural changes in the trigeminal nerve of patients with episodic migraine assessed using magnetic resonance imaging. J Headache Pain 21(1), 59 (2020).
Xie, G. et al. Anatomical assessment of trigeminal nerve tractography using diffusion MRI: A comparison of acquisition b-values and single- and multi-fiber tracking strategies. Neuroimage Clin. 25, 102160 (2020).
Liu, J., Zhu, J., Yuan, F., Zhang, X. & Zhang, Q. Abnormal brain white matter in patients with right trigeminal neuralgia: A diffusion tensor imaging study. J. Headache Pain 19(1), 46 (2018).
Wu, M., Jiang, X., Qiu, J., Fu, X. & Niu, C. Gray and white matter abnormalities in primary trigeminal neuralgia with and without neurovascular compression. J. Headache Pain 21(1), 136 (2020).
Chen, D. Q., Zhong, J., Chu, P. P. W., Fei Li, C. M. & Hodaie, M. Trigeminal neuralgia diffusivities using Gaussian process classification and merged group tractography. Pain 162(2), 361–371 (2021).
Chen, S. T. et al. Diffusion tensor imaging for assessment of microstructural changes associate with treatment outcome at one-year after radiofrequency Rhizotomy in trigeminal neuralgia. BMC Neurol. 19(1), 62 (2019).
DeSouza, D. D., Davis, K. D. & Hodaie, M. Reversal of insular and microstructural nerve abnormalities following effective surgical treatment for trigeminal neuralgia. Pain 156(6), 1112–1123 (2015).
Headache classification committee of the international headache society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia 38 (1), 1–211 (2018).
Tohyama, S., Walker, M. R., Zhang, J. Y., Cheng, J. C. & Hodaie, M. Brainstem trigeminal fiber microstructural abnormalities are associated with treatment response across subtypes of trigeminal neuralgia. Pain 162(6), 1790–1799 (2021).
Sayaci, E. Y. et al. Morphology of the trigeminal ganglion: Anatomical structures related to trigeminal radiofrequency rhizotomy. Acta Neurochir. (Wien). 164(6), 1551–1566 (2022).
Tsutsumi, S., Ono, H. & Ishii, H. Meckel cave: An anatomical study using magnetic resonance imaging. J. Comput. Assist. Tomogr. 45(5), 743–748 (2021).
Haller, S. et al. Imaging of neurovascular compression syndromes: Trigeminal neuralgia, hemifacial spasm, vestibular paroxysmia, and glossopharyngeal neuralgia. AJNR Am. J. Neuroradiol. 37(8), 1384–1392 (2016).
Leal, P. R. et al. Atrophic changes in the trigeminal nerves of patients with trigeminal neuralgia due to neurovascular compression and their association with the severity of compression and clinical outcomes. J. Neurosurg. 120(6), 1484–1495 (2014).
Rubinstein, D., Stears, R. L. G. & Stears, J. C. Trigeminal nerve and ganglion in the Meckel cave: Appearance at CT and MR imaging. Radiology 193(1), 155–159 (1994).
Du, C. et al. Air-to-air meeting technique in radiofrequency thermocoagulation of trigeminal neuralgia: A case report. Pain Pract. 21(5), 588–593 (2021).
Guo, Z. et al. Unconventional facial entry points confirmed using a 3D CT reconstruction-guided stereotactic approach to radiofrequency thermocoagulation for the treatment of trigeminal neuralgia: A series of case reports. Pain Med. 20(8), 1551–1558 (2019).
Li, S. T. et al. Trigeminal neuralgia: what are the important factors for good operative outcomes with microvascular decompression. Surg Neurol 62(5), 400–404 (2004) (discussion 4–5).
Arrighi-Allisan, A. E. et al. Neuroanatomical determinants of secondary trigeminal neuralgia: Application of 7T ultra-high-field multimodal magnetic resonance imaging. World Neurosurg. 137, e34–e42 (2020).
Leal, P. R. L. Fraction of anisotropy and apparent diffusion coefficient as diagnostic tools in trigeminal neuralgia. Acta Neurochir. (Wien) 161(7), 1403–1405 (2019).
Leal, P. R. L. et al. Structural abnormalities of the trigeminal root revealed by diffusion tensor imaging in patients with trigeminal neuralgia caused by neurovascular compression: A prospective, double-blind, controlled study. Pain 152(10), 2357–2364 (2011).
Moon, H. C. et al. 7.0Tesla MRI tractography in patients with trigeminal neuralgia. Magn. Reson. Imaging 54, 265–270 (2018).
Willsey, M. S., Collins, K. L., Conrad, E. C., Chubb, H. A. & Patil, P. G. Diffusion tensor imaging reveals microstructural differences between subtypes of trigeminal neuralgia. J. Neurosurg. 133, 573–579 (2019).
Willsey, M. S., Mossner, J. M., Chestek, C. A., Sagher, O. & Patil, P. G. Classifier using pontine radial diffusivity and symptom duration accurately predicts recurrence of trigeminal neuralgia after microvascular decompression: A pilot study and algorithm description. Neurosurgery 89(5), 777–783 (2021).
Wu, M. et al. Diffusion tensor imaging reveals microstructural alteration of the trigeminal nerve root in classical trigeminal neuralgia without neurovascular compression and correlation with outcome after internal neurolysis. Magn. Reson. Imaging 71, 37–44 (2020).
Lee, Y. L. et al. Diffusivity parameters of diffusion tensor imaging and apparent diffusion coefficient as imaging markers for predicting the treatment response of patients with trigeminal neuralgia. J. Neurosurg. 132(6), 1993–1999 (2019).
DeSouza, D. D., Hodaie, M. & Davis, K. D. Abnormal trigeminal nerve microstructure and brain white matter in idiopathic trigeminal neuralgia. Pain 155(1), 37–44 (2014).
Zhang, Y. et al. Diffusion tensor imaging of axonal and myelin changes in classical trigeminal neuralgia. World Neurosurg. 112, e597–e607 (2018).
Hung, P. S., Tohyama, S., Zhang, J. Y. & Hodaie, M. Temporal disconnection between pain relief and trigeminal nerve microstructural changes after Gamma Knife radiosurgery for trigeminal neuralgia. J. Neurosurg. 133, 727–735 (2019).
Borsook, D., DaSilva, A. F. M., Ploghaus, A. & Becerra, L. Specific and somatotopic functional magnetic resonance imaging activation in the trigeminal ganglion by brush and noxious heat. J. Neurosci. 23(21), 7897–7903 (2003).
Tohyama, S., Hung, P. S., Zhong, J. & Hodaie, M. Early postsurgical diffusivity metrics for prognostication of long-term pain relief after Gamma Knife radiosurgery for trigeminal neuralgia. J. Neurosurg. 131(2), 539–548 (2018).
Elawamy, A., Abdalla, E. E. M. & Shehata, G. A. Effects of pulsed versus conventional versus combined radiofrequency for the treatment of trigeminal neuralgia: A prospective study. Pain Physician 20(6), E873–E881 (2017).
Oturai, A. B., Jensen, K., Eriksen, J. & Madsen, F. Neurosurgery for trigeminal neuralgia: Comparison of alcohol block, neurectomy, and radiofrequency coagulation. Clin. J. Pain 12(4), 311–315 (1996).
Singh, S., Verma, R., Kumar, M., Rastogi, V. & Bogra, J. Experience with conventional radiofrequency thermorhizotomy in patients with failed medical management for trigeminal neuralgia. Korean J. Pain 27(3), 260–265 (2014).
Acknowledgements
The authors wish to acknowledge Jacqueline Gonzales for writing assistance and language editing of the manuscript. We would like to thank 3D slicer image computing platform (http://www.slicer.org/) for image processing.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
X.S., Z.M.W., Z.J.W., and M.C. contributed the clinical details. X.S., Z.M.W. designed the research and wrote the first draft of the article. C.D. and Y.T. revised the article. All authors have read, revised, and approved the final version of manuscript. The subject in this manuscript gave written informed consent for publication of this article and images.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Su, X., Wang, Z., Wang, Z. et al. A novel indicator to predict the outcome of percutaneous stereotactic radiofrequency rhizotomy for trigeminal neuralgia patients: diffusivity metrics of MR-DTI. Sci Rep 14, 9235 (2024). https://doi.org/10.1038/s41598-024-59828-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-59828-4
- Springer Nature Limited